A carregar...

Mortality Risk of Darbepoetin Alfa versus Epoetin Alfa in Patients with Chronic Kidney Disease: Systematic Review and Meta-Analysis

BACKGROUND: Epoetin alfa (EPO) and darbepoetin alfa (EPO) are erythropoiesis-stimulating agents that are widely and interchangeably used for the treatment of anemia in patients with advanced chronic kidney disease and end-stage renal disease. No studies have specifically compared the risks of hard s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Kidney Dis
Main Authors: Wilhelm-Leen, Emilee R., Winkelmayer, Wolfgang C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485593/
https://ncbi.nlm.nih.gov/pubmed/25636816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2014.12.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!